Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset still's disease

Journal of Rheumatology

Volumn 39, Issue 7, 2012, Pages 1399-1406

  Kim, Hyoun Ah ^a   An, Jeong Mi ^a   Nam, Jin Young ^a   Jeon, J A Young ^a   Suh, Chang Hee ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Adult onset still's disease; Biomarker; Disease activity; follistatin like protein 1; Interleukin 18; S100A8 A9

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; FERRITIN; FOLLISTATIN LIKE PROTEIN 1; FOLLISTATIN RELATED PROTEIN; INTERLEUKIN 18; UNCLASSIFIED DRUG;

ADULT; ADULT ONSET STILL DISEASE; ARTICLE; BLOOD SAMPLING; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE MARKER; DOWN REGULATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; UPREGULATION;

ADULT; AGE OF ONSET; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; FEMALE; FERRITINS; FOLLISTATIN-RELATED PROTEINS; HUMANS; INTERLEUKIN-18; LEUKOCYTE COUNT; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STILL'S DISEASE, ADULT-ONSET;

EID: 84863505053     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120079     Document Type: Article

References (39)

1. Bywaters EG. Still's disease in the adult. Ann Rheum Dis1971;30:121-33.
2. Fautrel B. Adult-onset Still disease. Best Pract Res Clin Rheumatol2008;22:773-92.
3. Pouchot J, Sampalis JS, Beaudet F, Carette S, Decary F,Salusinsky- Sternbach M, et al. Adult Still's disease: Manifestations,disease course, and outcome in 62 patients. Medicine1991;70:118-36.
4. Ohta A, Yamaguchi M, Kaneoka H, Nagayoshi T, Hiida M. AdultStill's disease: Review of 228 cases from the literature. J Rheumatol 1987;14:1139-46.
5. Efthimiou P, Kontzias A, Ward CM, Ogden NS. Adult-onset Still's disease: Can recent advances in our understanding of its pathogenesis lead to targeted therapy? Nat Clin Pract Rheumatol 2007;3:328-35. (Pubitemid 46864887)
6. Cagatay Y, Gul A, Cagatay A, Kamali S, Karadeniz A, Inanc M, et al. Adult-onset Still's disease. Int J Clin Pract 2009;63:1050-5.
7. Edgeworth J, Gorman M, Bennett R, Freemont P, Hogg N. Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J Biol Chem 1991;266:7706-13. (Pubitemid 21906422)
8. Foell D, Frosch M, Sorg C, Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 2004;344:37-51. (Pubitemid 38626135)
9. Raquil MA, Anceriz N, Rouleau P, Tessier PA. Blockade of antimicrobial proteins S100A8 and S100A9 inhibits phagocyte migration to the alveoli in streptococcal pneumonia. J Immunol 2008;180:3366-74.
10. Vogl T, Ludwig S, Goebeler M, Strey A, Thorey IS, Reichelt R, et al. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 2004;104:4260-8. (Pubitemid 39620181)
11. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007;13:1042-9. (Pubitemid 47517513)
12. Striz I, Wang YM, Svarcova I, Trnka L, Sorg C, Costabel U. The phenotype of alveolar macrophages and its correlation with immune cells in bronchoalveolar lavage. Eur Respir J 1993;6:1287-94. (Pubitemid 23329544)
13. van Zoelen MA, Vogl T, Foell D, Van Veen SQ, van Till JW, Florquin S, et al. Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. Am J Respir Crit Care Med 2009;180:1098-106.
14. Frosch M, Ahlmann M, Vogl T, Wittkowski H, Wulffraat N, Foell D, et al. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1-beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2009;60:883-91.
15. Frosch M, Vogl T, Seeliger S, Wulffraat N, Kuis W, Viemann D, et al. Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 2003;48:2622-6. (Pubitemid 37129439)
16. Jung SY, Park YB, Ha YJ, Lee KH, Lee SK. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease. J Rheumatol 2010;37:1029-34.
17. Shibanuma M, Mashimo J, Mita A, Kuroki T, Nose K. Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide. Eur J Biochem 1993;217:13-9. (Pubitemid 23305265)
18. Thornton S, Sowders D, Aronow B, Witte DP, Brunner HI, Giannini EH, et al. DNA microarray analysis reveals novel gene expression profiles in collagen-induced arthritis. Clin Immunol 2002;105:155-68. (Pubitemid 35471663)
19. Clutter SD, Wilson DC, Marinov AD, Hirsch R. Follistatin-like protein 1 promotes arthritis by up-regulating IFN-gamma. J Immunol 2009;182:234-9.
20. Tanaka M, Ozaki S, Osakada F, Mori K, Okubo M, Nakao K. Cloning of follistatin-related protein as a novel autoantigen in systemic rheumatic diseases. Int Immunol 1998;10:1305-14. (Pubitemid 28414336)
21. Wilson DC, Marinov AD, Blair HC, Bushnell DS, Thompson SD, Chaly Y, et al. Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 2010;62:2510-6.
22. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, et al. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 1996;156:4274-9. (Pubitemid 26165826)
23. Lotito AP, Campa A, Silva CA, Kiss MH, Mello SB. Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis. J Rheumatol 2007;34:823-30. (Pubitemid 46641392)
24. Dinarello CA. Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw 2000;11:483-6.
25. Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still'sdisease. Arthritis Rheum 2001;44:550-60. (Pubitemid 32234613)
26. Kawaguchi Y, Terajima H, Harigai M, Hara M, Kamatani N.Interleukin-18 as a novel diagnostic marker and indicator of diseaseseverity in adult-onset Still's disease. Arthritis Rheum2001;44:1716-7. (Pubitemid 32642237)
27. Choi JH, Suh CH, Lee YM, Suh YJ, Lee SK, Kim SS, et al. Serumcytokine profiles in patients with adult onset Still's disease. J Rheumatol 2003;30:2422-7. (Pubitemid 37413904)
28. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.
29. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
30. Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: Some answers, more questions. Nat Rev Rheumatol 2011;7:416-26.
31. Wittkowski H, Frosch M, Wulffraat N, Goldbach-Mansky R, Kallinich T, Kuemmerle-Deschner J, et al. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum 2008;58:3924-31.
32. Roth J, Vogl T, Sorg C, Sunderkotter C. Phagocyte-specific S100 proteins: A novel group of proinflammatory molecules. Trends Immunol 2003;24:155-8. (Pubitemid 36412096)
33. Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: A novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007;81:28-37. (Pubitemid 46021248)
34. Miyamae T, Marinov AD, Sowders D, Wilson DC, Devlin J, Boudreau R, et al. Follistatin-like protein-1 is a novel proinflammatory molecule. J Immunol 2006;177:4758-62. (Pubitemid 44469810)
35. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995;378:88-91.
36. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003;73:213-24. (Pubitemid 36158296)
37. Maeno N, Takei S, Nomura Y, Imanaka H, Hokonohara M, Miyata K. Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al. Arthritis Rheum 2002;46:2539-41; author reply 2541-32.
38. Jelusic M, Lukic IK, Tambic-Bukovac L, Dubravcic K, Malcic I, Rudan I, et al. Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis. Clin Rheumatol 2007;26:1332-4. (Pubitemid 47034191)
39. Fujii T, Nojima T, Yasuoka H, Satoh S, Nakamura K, Kuwana M, et al. Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology 2001;40:1398-404.